Treatment Of Partial Reversible Chronic Obstructive Pulmonary Disease
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to GlaxoSmithKline
Related studies linked through entity extraction aliases.
Optimising the Propranolol Block Model
- Status
- COMPLETED
- Phase
- PHASE1
Firategrast (SB683699) Surface Area Study in Multiple Sclerosis Patients
- Status
- COMPLETED
- Phase
- PHASE1
A Phase IIa Study Of Men And Post-Menopausal Women With A Fractured Distal Radius
- Status
- TERMINATED
- Phase
- PHASE2
Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Lapatinib and Trastuzumab With or Without Endocrine Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination in Study NCT01267058
- Status
- COMPLETED
- Phase
- PHASE4
Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines
- Status
- COMPLETED
- Phase
- PHASE3
Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America
- Status
- COMPLETED
- Phase
- PHASE2
SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis.
- Status
- COMPLETED
- Phase
- PHASE4
Revaccination With Influenza Vaccine GSK1247446A
- Status
- COMPLETED
- Phase
- PHASE2
Immunogenicity, Antibody Persistence and Safety of GSK Biologicals' DTPa (INFANRIX) and dTpa (BOOSTRIX) Vaccines.
- Status
- TERMINATED
- Phase
- PHASE4
Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs
- Status
- COMPLETED
- Phase
- PHASE1
Phase IIa Venous Thromboembolism (VTE) Prevention Study In Total Knee Replacement (TKR)
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Pazopanib, Irinotecan and Cetuximab in Combination to Treat 2nd Line Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Estimate the Effect of Formulation on the Relative Absorption of SB-751689 Administered to Healthy Women
- Status
- COMPLETED
- Phase
- PHASE1
Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A
- Status
- COMPLETED
- Phase
- PHASE2
Study to Test Safety, Tolerability and Blood Levels of GSK971086 After 1 Dose & 7 Days of Dosing in Healthy Adult Males
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Subjects
- Status
- WITHDRAWN
- Phase
- PHASE1